<?xml version="1.0" encoding="UTF-8"?>
<p>In 2016, EV-D68-associated AFM cases also rose notably in Europe [
 <xref rid="B57-viruses-11-00490" ref-type="bibr">57</xref>]. During 2018, the United Kingdom experienced an increase in reported AFP cases that coincided temporally with an upsurge in EV-D68 activity; EV-D68 was detected in the respiratory tracts of 37.5% of the diagnosed AFM cases [
 <xref rid="B58-viruses-11-00490" ref-type="bibr">58</xref>]. Moreover, as compared to 2017 (35 cases), the number of confirmed AFM cases (223) in 2018 in the US is significantly higher and has been accompanied by an increase in EV-D68 infection [
 <xref rid="B59-viruses-11-00490" ref-type="bibr">59</xref>]. The temporal and geographically link between the spread of EV-D68 and the clustering of AFM suggests a strong epidemiological correlation between EV-D68 and AFM.
</p>
